REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Exicure, Inc. (XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results